Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.

[1]  Minoru Ono,et al.  Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  L. Baddour,et al.  Clinical manifestations and management of left ventricular assist device-associated infections. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  T. Imamura,et al.  Successful weaning from the DuraHeart with a low left ventricular ejection fraction , 2013, Journal of Artificial Organs.

[4]  S. Miyagawa,et al.  DuraHeartTM Magnetically Levitated Left Ventricular Assist Device , 2013 .

[5]  K. Kinugawa,et al.  Improved survival in patients with continuous-flow ventricular assist device for bridge to heart transplantation. , 2013, Transplantation proceedings.

[6]  Y. Tanoue,et al.  A case of conversion of a NIPRO ventricular assist system to an EVAHEART left ventricular assist system , 2013, Journal of Artificial Organs.

[7]  G. Stevens,et al.  Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. , 2013, The Annals of thoracic surgery.

[8]  T. Imamura,et al.  Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device , 2013, Journal of Artificial Organs.

[9]  Robert L Kormos,et al.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  Yariv N. Marmor,et al.  Readmissions after implantation of axial flow left ventricular assist device. , 2013, Journal of the American College of Cardiology.

[11]  Vikas Sharma,et al.  Driveline infections in left ventricular assist devices: implications for destination therapy. , 2012, The Annals of thoracic surgery.

[12]  D. van Dijk,et al.  Cerebrovascular complications of left ventricular assist devices. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  S. Kitamura.  Heart transplantation in Japan: a critical appraisal for the results and future prospects , 2012, General Thoracic and Cardiovascular Surgery.

[14]  Marissa Miller,et al.  Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? , 2012, The Journal of thoracic and cardiovascular surgery.

[15]  B. Jensen,et al.  Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. , 2012, American heart journal.

[16]  Minoru Ono,et al.  New era for therapeutic strategy for heart failure: destination therapy by left ventricular assist device. , 2012, Journal of cardiology.

[17]  S. Miyagawa,et al.  Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[18]  Adrian F Hernandez,et al.  Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. , 2011, Circulation. Heart failure.

[19]  Josef Stehlik,et al.  The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  N. Smedira,et al.  Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. , 2011, The Annals of thoracic surgery.

[21]  Yoshifumi Naka,et al.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.

[22]  N. Oda,et al.  Pre- and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device. -Single center's experience in japan-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[23]  T. Nishinaka,et al.  Long-term circulatory support with a left ventricular assist device therapy in Japan. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[24]  R. Hetzer,et al.  European results with a continuous-flow ventricular assist device for advanced heart-failure patients. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  M. Morshuis,et al.  European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  Heinrich Schima,et al.  The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-to-transplant experience. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[27]  Mitsuo Umezu,et al.  EVAHEART: an implantable centrifugal blood pump for long-term circulatory support. , 2002, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[28]  M. Ono,et al.  Successful treatment of pump pocket infection after left ventricular assist device implantation by negative pressure wound therapy and omental transposition. , 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[29]  Nader Moazami,et al.  Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.

[30]  A. Hoffmeier,et al.  Initial clinical experience with the HeartWare left ventricular assist system: a single-center report. , 2013, The Annals of thoracic surgery.

[31]  K. Kinugawa.  How to Treat Stage D Heart Failure , 2011 .

[32]  S. Morita.  An old ventricular assist device still working for patients with end-stage heart failure in Japan. , 2011, Circulation journal : official journal of the Japanese Circulation Society.